BIN2 inhibition suppress ovarian cancer progression meanwhile protect ovarian function through downregulating HDAC1 and RPS6 phosphorylation respectively

Cong-Rong Li; Shi-Ya Xie; Shu-Ping Zhang; Yan-Jie Yang; Li-Li Yang; Ying Cao; Li-Li Wang; Feng-Yu Zhu; Ruo-Lei Wang; Zhi-Xia Yang; Chen-Chen Cui; Yan-Ru Li; Jia-Ning Xu; Feng Yue; Pei-Zhe Tian; Qian Wang; Hong-Jie Yao; Yi-Chun Guan; Shao-Di Zhang; Xiao-Yan Ying; Dong Zhang; Cui-Lian Zhang

doi:10.1002/ctm2.70051

Clinical and Translational Medicine ›› 2024, Vol. 14 ›› Issue (10) : e70051 DOI: 10.1002/ctm2.70051

LETTER TO THE JOURNAL

BIN2 inhibition suppress ovarian cancer progression meanwhile protect ovarian function through downregulating HDAC1 and RPS6 phosphorylation respectively

Cong-Rong Li ¹^,²^,³^,⁴
, Shi-Ya Xie ¹^,²^,³^,⁴
, Shu-Ping Zhang ¹^,²^,³^,⁴
, Yan-Jie Yang ¹^,²^,³^,⁴
, Li-Li Yang ⁵
, Ying Cao ⁵
, Li-Li Wang ²
, Feng-Yu Zhu ²
, Ruo-Lei Wang ²
, Zhi-Xia Yang ¹
, Chen-Chen Cui ⁶
, Yan-Ru Li ⁶
, Jia-Ning Xu ⁶
, Feng Yue ⁶
, Pei-Zhe Tian ⁶
, Qian Wang ⁶
, Hong-Jie Yao ⁷
, Yi-Chun Guan ⁸
, Shao-Di Zhang ⁶^,^†
, Xiao-Yan Ying ⁵^,^†
, Dong Zhang ¹^,²^,³^,⁴^,^†
, Cui-Lian Zhang ⁶^,^†

Author information +

¹. Department of Gynaecology and Obstetrics, the First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China

². State Key Lab of Reproductive Medicine and Offspring Health, Nanjing Medical University, Nanjing, Jiangsu, China

³. NHC Key Laboratory of Study on Abnormal Gametes and Reproductive Tract, Anhui Medical University, Hefei, Anhui, China

⁴. Key Laboratory of Population Health Across Life Cycle (Anhui Medical University), Ministry of Education of the People’s Republic of China, Hefei, Anhui, China

⁵. Department of Gynaecology and Obstetrics, the Second Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China

⁶. Reproductive Medical Center, Henan Provincial People’s Hospital & People’s Hospital of Zhengzhou University, Zhengzhou, Henan, China

⁷. Guangzhou National Laboratory, University of Chinese Academy of Sciences, Guangzhou, Guangdong, China

⁸. Center for Reproductive Medicine, the Third Affiliate Hospital of Zhengzhou University, Zhengzhou, Henan, China

zhangshd@126.com

xiaoyanying_cool@163.com

dong.ray.zhang@ahmu.edu.cn

luckyzcl@qq.com

Show less

History +

PDF

Cite this article

Download citation ▾

Cong-Rong Li, Shi-Ya Xie, Shu-Ping Zhang, Yan-Jie Yang, Li-Li Yang, Ying Cao, Li-Li Wang, Feng-Yu Zhu, Ruo-Lei Wang, Zhi-Xia Yang, Chen-Chen Cui, Yan-Ru Li, Jia-Ning Xu, Feng Yue, Pei-Zhe Tian, Qian Wang, Hong-Jie Yao, Yi-Chun Guan, Shao-Di Zhang, Xiao-Yan Ying, Dong Zhang, Cui-Lian Zhang. BIN2 inhibition suppress ovarian cancer progression meanwhile protect ovarian function through downregulating HDAC1 and RPS6 phosphorylation respectively. Clinical and Translational Medicine, 2024, 14(10): e70051 DOI:10.1002/ctm2.70051

登录浏览全文

4963

注册一个新账户忘记密码

References

Publishing order | Descend order by publishing year | Descend order by cited within

[1]	Reid F, Bajwa A, The World Ovarian Cancer Coalition Atlas. World Ovarian Cancer Coalition; 2023.

[2]	Mertins P, Mani DR, Ruggles KV, et al. Proteogenomics connects somatic mutations to signalling in breast cancer. Nature. 2016; 534(7605): 55-62.

[3]	Bian Y, Song C, Cheng K, et al. An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome. J Proteomics. 2014; 96: 253-262.

[4]	Schweppe DK, Rigas JR, Gerber SA. Quantitative phosphoproteomic profiling of human non-small cell lung cancer tumors. J Proteomics. 2013; 91: 286-296.

[5]	Zhu FY, Wang LL, Meng TG, et al. Inhibiting bridge integrator 2 phosphorylation leads to improved oocyte quality, ovarian health and fertility in aging and after chemotherapy in mice. Nat Aging. 2021; 1(11): 1010-1023.

[6]	Lin YC, Lin YC, Shih JY, et al. DUSP1 expression induced by HDAC1 inhibition mediates gefitinib sensitivity in non-small cell lung cancers. Clin Cancer Res. 2015; 21(2): 428-438.

[7]	Bahl S, Ling H, Acharige NPN, Santos-Barriopedro I, Pflum MKH, Seto E. EGFR phosphorylates HDAC1 to regulate its expression and anti-apoptotic function. Cell Death Dis. 2021; 12(5): 469.

[8]	Khateb A, Deshpande A, Feng Y, et al. The ubiquitin ligase RNF5 determines acute myeloid leukemia growth and susceptibility to histone deacetylase inhibitors. Nat Commun. 2021; 12(1): 5397.

[9]	Nagarajan S, Rao SV, Sutton J, et al. ARID1A influences HDAC1/BRD4 activity, intrinsic proliferative capacity and breast cancer treatment response. Nat Genet. 2020; 52(2): 187-197.

[10]	Butler LM, Webb Y, Agus DB, et al. Inhibition of transformed cell growth and induction of cellular differentiation by pyroxamide, an inhibitor of histone deacetylase. Clin Cancer Res. 2001; 7(4): 962-970.

RIGHTS & PERMISSIONS

2024 The Author(s). Clinical and Translational Medicine published by John Wiley & Sons Australia, Ltd on behalf of Shanghai Institute of Clinical Bioinformatics.